WJOG6110B (ELTOP): Randomized phase II trial comparing trastuzumab plus capecitabine (HX) and lapatinib plus capecitabine (LX) in HER2-positive metastatic breast cancer patients previously treated with trastuzumab and taxanes.
Toshimi Takano
No relevant relationships to disclose
Hideharu Kimura
No relevant relationships to disclose
Kazuto Nishio
No relevant relationships to disclose
Takeharu Yamanaka
No relevant relationships to disclose
Yoshinori Ito
No relevant relationships to disclose
Junya Fukuoka
No relevant relationships to disclose
Junji Tsurutani
No relevant relationships to disclose
Yasushi Shigeoka
No relevant relationships to disclose
Masahiro Uehara
No relevant relationships to disclose
Kazuhiko Sato
No relevant relationships to disclose
Shinichiro Nakamura
No relevant relationships to disclose
Yoichi Nakanishi
No relevant relationships to disclose
Toshiaki Saeki
No relevant relationships to disclose